Website & contact details
- Website
British Society for Gene and Cell Therapy
- Incorporated
- 14 November 2003 (22 years)
- Previously known as
- British Society for Gene Therapy (until 5 September 2012)
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Directors
- Stuart Anthony NicklinGerard Mclachlan
- Controlled by
- Rajvinder KardaStuart Anthony NicklinGerard Mclachlan
- Accounts type
- Micro entity
- Region
- Greater London
- Address
- 86-96 Chenies MewsLondonWC1E 6HX
Filing status
- Accounts due
- 28 February 2027
- Last accounts
- 31 May 2025
- Conf. stmt due
- 14 June 2027
- Last conf. stmt
- 31 May 2026
Officers 3 active
Officer details are public data from the Companies House register.
Karda, Rajvinder, Professor
Secretary · Appointed 17 April 2026
Nicklin, Stuart Anthony, Professor
Director · Appointed 20 June 2025
British
Born October 1972 (54)
Mclachlan, Gerard, Dr
Director · Appointed 18 June 2024
British
Born June 1966 (60)
Officer history (17 former)
17 April 2026
Resigned Barbaric, Ivana, Professor as Secretary
17 April 2026
Appointed Karda, Rajvinder, Professor as Secretary
20 June 2025
Appointed Nicklin, Stuart Anthony, Professor as Director
20 June 2025
Resigned Yáñez-Muñoz, Rafael Joaquín, Professor as Director
18 June 2024
Resigned Parker, Alan Leslie, Professor as Director
18 June 2024
Appointed Mclachlan, Gerard, Dr as Director
23 June 2023
Appointed Barbaric, Ivana, Professor as Secretary
23 June 2023
Resigned Nicklin, Stuart Anthony, Professor as Secretary
19 October 2021
23 November 2020
Appointed Parker, Alan Leslie, Professor as Director
4 July 2019
Appointed Nicklin, Stuart Anthony, Professor as Secretary
4 July 2019
Resigned Bradshaw, Angela Claire, Dr as Secretary
27 April 2018
Appointed Bradshaw, Angela Claire, Dr as Secretary
27 April 2018
Resigned Nicklin, Stuart Anthony, Dr as Secretary
20 April 2017
15 April 2016
Appointed Yáñez-Muñoz, Rafael Joaquín, Professor as Director
28 March 2014
Appointed Nicklin, Stuart Anthony, Dr as Secretary
28 March 2014
Resigned Buckley, Suzy, Dr as Secretary
19 April 2013
9 March 2012
Resigned Mautner, Vivien as Director
9 March 2012
9 March 2012
Resigned Antoniou, Michael, Doctor as Director
5 May 2011
3 December 2010
Resigned Mautner, Vivien as Secretary
2 December 2010
Appointed Buckley, Suzy, Dr as Secretary
21 October 2009
7 October 2009
Resigned Seymour, Leonard William, Professor as Director
1 January 2008
Appointed Antoniou, Michael, Doctor as Director
1 January 2008
Appointed Mautner, Vivien as Director
1 January 2008
Appointed Mautner, Vivien as Secretary
31 December 2007
Resigned Dickson, George, Professor as Secretary
31 December 2007
31 December 2007
Resigned Dickson, George, Professor as Director
14 November 2003
Appointed Dickson, George, Professor as Secretary
14 November 2003
14 November 2003
Appointed Dickson, George, Professor as Director
14 November 2003
Appointed Seymour, Leonard William, Professor as Director
Ownership 3 active
People and entities with significant control, from the Companies House PSC register
Rajvinder Karda
Individual · Notified 17 April 2026
Has significant influence or control
British
Born April 1989 (37)
Stuart Anthony Nicklin
Individual · Notified 20 June 2025
Has significant influence or control
British
Born October 1972 (54)
Gerard Mclachlan
Individual · Notified 18 June 2024
Has significant influence or control
British
Born June 1966 (60)
Former controllers (8)
17 April 2026
Ceased Ivana Barbaric — Has significant influence or control
20 June 2025
Ceased Rafael Joaquín Yáñez-Muñoz — Has significant influence or control
18 June 2024
Ceased Alan Leslie Parker — Has significant influence or control
23 June 2023
Ceased Stuart Anthony Nicklin — Has significant influence or control
19 October 2021
4 July 2019
Ceased Angela Claire Bradshaw — Has significant influence or control
27 April 2018
Ceased Stuart Anthony Nicklin — Has significant influence or control
20 April 2017
Financials
Balance sheet as at 31 May 2025 · micro entity accounts
- Net Assets
- £158,029
- Debt Ratio
- 0%
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Fixed Assets | £0 | £0 | £0 | ||
| Current Assets | £158,029 | £187,502 | £170,698 | £50,380 | £63,148 |
| Creditors (< 1 year) | £0 | £0 | £0 | ||
| Creditors (> 1 year) | £0 | £0 | £0 | ||
| Net Current Assets | £158,029 | £187,502 | £170,698 | £50,380 | £63,148 |
| Net Assets | £158,029 | £187,502 | £170,698 | £50,380 | £63,148 |
| Shareholder Funds | £158,029 | £187,502 | £170,698 | £50,380 | £63,148 |
What British Society For Gene And Cell Therapy say about themselves
“Supporting progress & translation of gene & cell therapies”
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 4 June 2026 | Registered office address changed | |||
| 4 June 2026 | Confirmation statement with no updates | 31 May 2026 | ||
| 24 April 2026 | Registered office address changed | |||
| 24 April 2026 | Notification of a person with significant control | |||
| 17 April 2026 | Termination of appointment of a secretary |
Other companies in this industry
Oxford
Cambridge
Coventry
Weybridge
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →